Skip to main content
Pancreatic enzyme insufficiency patient confused about pancreatic enzyme therapy prescription
Busting the Myths about Pancreatic Enzymes for Pancreatitis


Mar 7, 2019 1:29 PM Eastern Time (US and Canada)

Webinar logo
* Required information


Dr. Steven D. Freedman
Dr. Steven D. Freedman @Beth Israel Deaconess Medical Center and Harvard Medical School
Steven D. Freedman M.D., Ph.D. is Director of the Pancreas Center at Beth Israel Deaconess Medical Center, Chief of the Division of Translational Research, and Professor of Medicine at Harvard Medical School. Dr. Freedman received his Ph.D. from Yale University School of Medicine followed by the M.D. degree at the University of Connecticut. He completed his residency and fellowship in Gastroenterology at Beth Israel Hospital and has remained on faculty since 1991. Dr. Freedman’s expertise is in exocrine pancreatic disease with a particular focus on pancreatitis and cystic fibrosis. He is an internationally recognized leader in these areas with an extensive research program that encompasses both basic science discovery as well as clinical trials. He has also been a leader in identifying the site in the brain where pancreatic visceral pain is represented, has developed molecular signatures of pain using MR Spectroscopy, and has successfully developed pain therapies using TMS.